Further exploration of the consistently modulated genes, particularly FN1, PIK3R1, and TGFBR1, may reveal new molecular insights and therapeutic targets for managing aggressive thyroid cancers. The gene discussed is PIK3R1; the disease is thyroid gland carcinoma.